Association of Non-Pharmaceutical Interventions to Reduce the Spread of SARS-CoV-2 With Anxiety and Depressive Symptoms: A Multi-National Study of 43 Countries

Int J Public Health. 2022 Mar 3:67:1604430. doi: 10.3389/ijph.2022.1604430. eCollection 2022.

Abstract

Objectives: To examine the association of non-pharmaceutical interventions (NPIs) with anxiety and depressive symptoms among adults and determine if these associations varied by gender and age. Methods: We combined survey data from 16,177,184 adults from 43 countries who participated in the daily COVID-19 Trends and Impact Survey via Facebook with time-varying NPI data from the Oxford COVID-19 Government Response Tracker between 24 April 2020 and 20 December 2020. Using logistic regression models, we examined the association of [1] overall NPI stringency and [2] seven individual NPIs (school closures, workplace closures, cancellation of public events, restrictions on the size of gatherings, stay-at-home requirements, restrictions on internal movement, and international travel controls) with anxiety and depressive symptoms. Results: More stringent implementation of NPIs was associated with a higher odds of anxiety and depressive symptoms, albeit with very small effect sizes. Individual NPIs had heterogeneous associations with anxiety and depressive symptoms by gender and age. Conclusion: Governments worldwide should be prepared to address the possible mental health consequences of stringent NPI implementation with both universal and targeted interventions for vulnerable groups.

Keywords: COVID-19; age; anxiety; depression; gender; non-pharmaceutical interventions.

MeSH terms

  • Adult
  • Anxiety / epidemiology
  • Anxiety / prevention & control
  • Anxiety Disorders
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Depression / epidemiology
  • Depression / prevention & control
  • Humans
  • SARS-CoV-2*